Vascular Regenerative Cell Flux in Diabetes: Mechanistic and Clinical Implications.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42574077.
- Also identified by DOI 10.2337/db26-0372.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Vascular regenerative cells, including endothelial precursor cells and hematopoietic progenitor cells, exhibit altered regenerative function in type 2 diabetes. Traditional definitions of endothelial precursor cells lack phenotypic specificity, limiting interpretation of regenerative capacity across studies. Functional assays, including colony formation, migration, and in vivo ischemic models for type 2 diabetes, have revealed defects in angiogenesis, proliferation, and repair. Emerging omics approaches provide mechanistic insight into vascular regenerative cell exhaustion across metabolic and inflammatory states. Standardized phenotyping and functional assays are needed to improve the translational success of regenerative therapies for cardiometabolic diseases.